Top View
- Efficacy of Alogliptin Or Dapagliflozin Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus
- Or Repaglinide-Based Combination Therapy with Alogliptin in Drug-Naïve Patients with Type 2 Di
- KAZANO (Alogliptin and Metformin Hcl) Tablets, for Oral Use KAZANO
- Type I Diabetes Treatments Clinical Notes Recommendations
- Pharmacy Department Updates
- ACCEPTABLE COMBINATIONS of DIABETES MEDICATIONS (Updated 01/27/2021)
- Nesina™ (Alogliptin), Kazano
- MEDICATIONS Staying up to Date with the Latest Blood Glucose–Lowering Medications Is
- Journal of Nippon Medical School Vol.88 No.1
- Diabetes Medication Instructions
- Diabetes in Adults
- Clinical Review Hyon Kwon, Pharmd, MPH Snda 208751/S-010 and S-011 Fiasp (Insulin Aspart)
- DPP-4 Inhibitors
- Position Statement for Alogliptin
- 09/20/2018 Medi-Cal Formulary Change for Januvia, Janumet and Janumet XR
- (DPP-4) Inhibitors Reference Number: CP.PMN.03 Effective Date: 09.19.18 Last Review Date: 02.21 Line of Business: Medicaid Revision Log
- New Diabetes Medications Barbara Hettinger, MD Phd Staff Endocrinologist, Portland VA Health Care System Assistant Professor, OHSU Endocrinology Disclosures
- 022271Orig1s000
- Healthy Blue Hot Tip: Diabetes
- Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin
- Pharmacy Medical Policy Diabetes Step Therapy
- MEDICATION GUIDE Alogliptin and Pioglitazone Tablets Read This
- Construction of Effective and Safe Glycemic Control in the Elderly by Using Continuous Glucose Monitoring
- MEDICATION GUIDE Alogliptin and Metformin Hcl Tablets Read This
- Saxagliptin and Alogliptin Safety Communication
- Management of Diabetes Before and After Surgery Or Procedure
- Therapeutic Class Overview Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- Antidiabetic Agents – Unified Formulary
- Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids
- (Qtern), Dapagliflozin/Saxagliptin/Metformin (Qternmet
- Vipdomet, Alogliptin+Metformin Hydrochloride
- NESINA (Alogliptin) Tablets • Hypersensitivity: There Have Been Postmarketing Reports of Initial U.S
- Diabetes Medications Timeline of Insulin Therapies in the US
- Package Leaflet: Information for the Patient Vipidia 25 Mg Film-Coated Tablets Vipidia 12.5 Mg Film-Coated Tablets Vipidia 6.25
- PRODUCT MONOGRAPH Prnesina®
- Dapagliflozin Is Effective As Add-On Therapy to Sitagliptin with Or Without Metformin
- Dipeptidyl Peptidase-4 Inhibitors
- MEDICATION GUIDE Alogliptin Tablets Read This Medication Guide Carefully Before You Start Taking Alogliptin Tablets and Each Time You Get a Refill
- 5.01.569 Pharmacotherapy of Type I and Type II Diabetes Mellitus
- Diabetes Medications Dosing Guide
- Alogliptin Switch Procedure
- Public Assessment Reports for These Products
- Alogliptan Benzoate
- Comment on Mita Et Al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients
- DPP-4 Inhibitors Vs. SGLT-2 Inhibitors; Cons and Pros Xourgia E, Papazafiropoulou AK*, Karampousli E and Melidonis A
- Effect of Alogliptin, a DPP-4 Inhibitor, on Markers of Lipid Metabolism In
- FDA Warns That DPP-4 Inhibitors for Type 2 Diabetes May Cause Severe Joint Pain
- Page 31 of 33 MEDICATION GUIDE NESINA (Nes-See′-Na)
- KAZANO Safely and Effectively
- Antihyperglycemic Agents Comparison Chart
- Alogliptin (Vipidia™) Sitagliptin(Januvia™) and Linagliptin (Trajenta™) for Type 2 Diabetes
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Annual Review Date: Preferred Step Therapy Policy 03/18/2021
- Vipidia, INN-Alogliptin
- 209196Orig1s000
- FDA Drug Safety Communication: FDA Adds Warnings About Heart Failure Risk to Labels of Type 2 Diabetes Medicines Containing Saxagliptin and Alogliptin
- Diabetes in Primary Care; Getting A1C to Goal. Generics to Novel Agents
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- MEDICATION GUIDE KAZANO (Kah-ZAHN-Oh) (Alogliptin and Metformin Hcl)